Kiora Pharmaceuticals, Inc.

This study tests an experimental drug called KIO-104, given as an injection into the eye, for people with macular edema (swelling in the back of the eye). The main goal is to check if the drug is safe and tolerable. About 28 adults aged 18 to 85 will receive multiple doses over s…

This study tests an experimental drug called KIO-301, given as an eye injection, for people with late-stage retinitis pigmentosa—a disease that causes vision loss. The trial includes 36 adults who have no light perception or very low vision. Participants will receive up to three …